Cycling Initiative to Raise Cancer Research Funds in Japan
Employees will cycle 1,800 kilometers starting October 6 to support global cancer research and treatment institutions.
Updated on Oct. 16, 2026 in Cancer

Live Poll
Do you believe large companies should organize employee athletic events to raise funds for charitable causes?
More than 55 employees from Bristol Myers Squibb are set to begin a 1,800-kilometer cycling initiative across Japan on October 6, 2026. This 15-day event aims to raise funds to support cancer research and patients globally.
Why it matters
The initiative underscores the role of corporate philanthropy in funding cancer research, with proceeds in India specifically directed to Tata Memorial Hospital. These efforts support the broader need for sustained financial resources to advance clinical care for cancer patients.
The global C2C4C initiative has accumulated over US$21 million in total donations since its 2013 inception. The specific impact of the 2026 fundraising goal remains currently unknown.
The players
Bristol Myers Squibb
A global biopharmaceutical company focused on the discovery and development of medicines for oncology and immunology.
Tata Memorial Hospital
A prominent cancer research and treatment center in India that is a beneficiary of the event's fundraising.
The details
The event involves 55 employees organized into five teams, who will complete distinct three-day cycling segments over the 15-day period. Riders will navigate a route covering nearly 1,800 kilometers, beginning from Tokyo Bay and concluding in Otemachi, Tokyo. Funds raised during the initiative are directed toward cancer research organizations worldwide.
Timeline
October 6 to October 20, 2026: The 15-day cycling event takes place in Japan.
Health Landscape
The C2C4C cycling initiative is now in its 13th year of operation, marking a long-term commitment to bridging the gap between corporate philanthropy and oncology research. This effort fits into the larger trend of private-sector support for independent medical research institutions.
While this cycling initiative highlights the ongoing need for cancer research funding, it serves as a reminder of the value of proactive health screenings and consulting with a doctor about individual cancer risk factors. Patients interested in supporting local research may discuss opportunities for participating in clinical trials with their oncologist.
The takeaway
The C2C4C initiative illustrates how community and corporate efforts provide critical support for oncology research centers like Tata Memorial Hospital. Readers should stay informed about cancer prevention guidelines and discuss routine screening options with their primary care physician.
Further reading
Learn more about the latest innovations and developments in the field by visiting our Cancer section.
Source note: This article includes information reported by Pharmabiz.
Live Poll
Do you believe large companies should organize employee athletic events to raise funds for charitable causes?






